Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.95 USD | +0.29% | -0.64% | +48.72% |
May. 24 | Barclays Adjusts Price Target on Alvotech to $22 From $20, Maintains Overweight Rating | MT |
May. 22 | Transcript : Alvotech, Q1 2024 Earnings Call, May 22, 2024 |
Financials (USD)
Sales 2024 * | 411M | Sales 2025 * | 614M | Capitalization | 3.89B |
---|---|---|---|---|---|
Net income 2024 * | -79M | Net income 2025 * | 31M | EV / Sales 2024 * | 13 x |
Net Debt 2024 * | 1.46B | Net Debt 2025 * | 1.28B | EV / Sales 2025 * | 8.41 x |
P/E ratio 2024 * |
-49
x | P/E ratio 2025 * |
143
x | Employees | 999 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 35.84% |
Latest transcript on Alvotech
1 day | +0.29% | ||
Current month | +48.72% | ||
Current year | +48.72% |
Managers | Title | Age | Since |
---|---|---|---|
Vilhelm Wessman
CEO | Chief Executive Officer | 54 | 12-12-31 |
Joel Morales
DFI | Director of Finance/CFO | 46 | 20-01-31 |
Giedrius Zunda
CTO | Chief Tech/Sci/R&D Officer | - | 22-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Linda McGoldrick
BRD | Director/Board Member | 69 | 22-06-15 |
Helga Zharov
LAW | General Counsel | 57 | 20-04-30 |
Vilhelm Wessman
CEO | Chief Executive Officer | 54 | 12-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 13.95 | +0.36% | 39,709 |
24-06-04 | 13.9 | -0.43% | 119,555 |
24-06-03 | 13.96 | +0.58% | 172,944 |
24-05-31 | 13.88 | +0.80% | 187,524 |
24-05-30 | 13.77 | +1.36% | 121,246 |
Delayed Quote Nyse, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+55.70% | 55.7B | |
+41.08% | 39.91B | |
-5.39% | 39.57B | |
-5.56% | 28.16B | |
+16.46% | 26.3B | |
-20.56% | 18.94B | |
+33.03% | 12.17B | |
+25.85% | 12.12B | |
+2.72% | 12.12B |
- Stock Market
- Equities
- ALVO Stock
- ALVO Stock